Newsletter Archive

41. 06.29.26 -- From Clinical To Market: Managing Pharma's Most Challenging Transition 6/29/2026
    06/29/26 Life Science Leader Newsletter
42. 06.28.26 -- Will FDA's Plausible Mechanism Framework Unleash More Cures? 6/28/2026
    06/28/26 Life Science Leader Newsletter
43. 06.25.26 -- Smarter risk management for single-use and filtration systems. 6/25/2026
    06/25/26 Life Science Leader Newsletter
44. 06.24.26 -- Five Ways To Unleash The Potential Of Women In STEM 6/24/2026
    06/24/26 Life Science Leader Newsletter
45. 06.22.26 -- The State Of FDA And Global Regulations For Radiopharmaceuticals 6/22/2026
    06/22/26 Life Science Leader Newsletter
46. 06.21.26 -- Why Do So Many New Drug Launches Fail To Meet Expectations? 6/21/2026
    06/21/26 Life Science Leader Newsletter
47. 06.18.26 -- Reduce mAb Aggregates: Practical Strategies 6/18/2026

    06/18/26 Life Science Leader Newsletter

48. 06.17.26 -- Five Reasons The Hub-And-Spoke Model Is Gaining Traction In Biotech 6/17/2026
    06/17/26 Life Science Leader Newsletter
49. 06.14.26 -- The Biotech Hub-And-Spoke Model Comes Of Age 6/14/2026
    06/14/26 Life Science Leader Newsletter
50. 06.13.26 -- Life Science Leader Newsletter - Best Of May 6/13/2026
    06/13/26 Life Science Leader Newsletter